BNC KOREA, Inc. (KOSDAQ: A256840)
Health Care · Biotechnology · KR
₩3,060.00
-3.01% today · -36.6% 1Y
BNC KOREA, Inc. (KOSDAQ: A256840) operates in the Biotechnology industry within the Health Care sector. The company is valued at $155.68M.
Over the last twelve months the share price has lost 36.6%, trading between 2.05K and 6.18K.
Tweenvest scores BNC KOREA, Inc. across four factors: quality 84/100, value 54/100. Its strongest factor is quality.
A256840 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $155.68M
- Revenue (TTM)
- $58.88M
- P/E
- —
- EPS
- -68.98
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- ₩6,180.00
- 52-week low
- ₩2,050.00
- Avg volume (3M)
- —
- Shares outstanding
- 68.39M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Satellos Bioscience Inc.TSX: MSCL | $159.25M | CA$10.71 | -10.82% |
| Coherus Oncology, Inc.NasdaqGM: CHRS | $159.14M | $1.03 | -3.74% |
| Organogenesis Holdings Inc.NasdaqCM: ORGO | $158.27M | $1.23 | -4.65% |
| Jyong Biotech Ltd.NasdaqGM: MENS | $155.89M | $2.10 | 0.00% |
| Helixmith Co., LtdKOSDAQ: A084990 | $155.16M | ₩4,530.00 | +22.60% |
| Innovacell Inc.TSE: 504A | $155.13M | ¥544.00 | -9.63% |
| Mycenax Biotech Inc.TPEX: 4726 | $154.11M | NT$23.80 | +2.59% |
| Tiziana Life Sciences LtdNasdaqCM: TLSA | $153.88M | $1.09 | -8.40% |
Figures last refreshed Oct 11, 2026.